Extracapsular extension on MRI indicates a more aggressive cell cycle progression genotype of prostate cancer

PurposeTo explore associations between magnetic resonance imaging (MRI) features of prostate cancer and expression levels of cell cycle genes, as assessed by the Prolaris((R)) test.Materials and methodsRetrospective analysis of 118 PCa patients with genetic testing of biopsy specimen and prostate MRI from 08/2013 to 11/2015. Associations between the cell cycle risk (CCR) score and MRI features [i.e., PI-RADSv2 score, extracapsular extension (ECE), quantitative metrics] were analyzed with Fisher's exact test, nonparametric tests, and Spearman's correlation coefficient. In 41 patients (34.7%), test results were compared to unfavorable features on prostatectomy specimen (i.e., Gleason group3, ECE, lymph node metastases).ResultsFifty-four (45.8%), 60 (50.8%), and 4 (3.4%) patients had low-, intermediate-, and high-risk cancers according to American Urological Association scoring system. Patients with ECE on MRI had significantly higher mean CCR scores (reader 1: 3.9 vs. 3.2, p=0.015; reader 2: 3.6 vs. 3.2, p=0.045). PI-RADSv2 scores and quantitative MRI features were not associated with CCR scores. In the prostatectomy subset, ECE on MRI (p=<0.001-0.001) and CCR scores (p=0.049) were significantly associated with unfavorable histopathologic features.ConclusionThe phenotypic trait of ECE on MRI indicates a more aggressive genotype of prostate cancer.